Discussed in
// RECENT MENTIONS
// SIGNALS
5 SIGNALS
01
mention·All In·OCTOBER 12, 2026
Source→02
funding·StrictlyVC·SEPTEMBER 30, 2026
“Link Cell Therapies, CAR-T developer using marker-combination activation, raised a $30 million Series A round led by Johnson & Johnson with BMS participation.”
Source→03
m_and_a·PitchBook News·AUGUST 4, 2026
“AstraZeneca is in talks to combine with peer pharmaceutical company Bristol Myers Squibb in a deal that would create a company valued at around $400 billion.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.